The cost-effectiveness of harm reduction.

  title={The cost-effectiveness of harm reduction.},
  author={David Peter Wilson and Braedon Donald and Andrew J Shattock and David A. J. Wilson and Nicole Fraser-Hurt},
  journal={The International journal on drug policy},
  volume={26 Suppl 1},
HIV prevalence worldwide among people who inject drugs (PWID) is around 19%. Harm reduction for PWID includes needle-syringe programs (NSPs) and opioid substitution therapy (OST) but often coupled with antiretroviral therapy (ART) for people living with HIV. Numerous studies have examined the effectiveness of each harm reduction strategy. This commentary discusses the evidence of effectiveness of the packages of harm reduction services and their cost-effectiveness with respect to HIV-related… CONTINUE READING

From This Paper

Topics from this paper.
12 Citations
80 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 12 extracted citations


Publications referenced by this paper.
Showing 1-10 of 80 references

Aid to Developing countries rebounds in 2013 to reach an all-time high

  • OECD.
  • OECD, Editor.
  • 2014

Similar Papers

Loading similar papers…